Low-Dose Levothyroxine Reduces Intrahepatic Lipid Content in Patients With Type 2 Diabetes Mellitus and NAFLD-Reference-Cited by-同舟云学术

Low-Dose Levothyroxine Reduces Intrahepatic Lipid Content in Patients With Type 2 Diabetes Mellitus and NAFLD

Published:2018-04-27 Issue:7 Volume:103 Page:2698-2706
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Bruinstroop Eveline¹²,Dalan Rinkoo³⁴,Cao Yang⁵,Bee Yong Mong⁶,Chandran Kurumbian⁷,Cho Li Wei⁸,Soh Shui Boon⁸,Teo Eng Kiong⁹,Toh Sue-Anne¹⁰,Leow Melvin Khee Shing¹³¹¹,Sinha Rohit A¹,Sadananthan Suresh Anand¹¹,Michael Navin¹¹,Stapleton Heather M¹²,Leung Christopher¹³¹⁴¹⁵,Angus Peter W¹³¹⁴,Patel Sheila K¹³,Burrell Louise M¹³¹⁵,Lim Su Chi¹⁶¹⁷,Sum Chee Fang¹⁶¹⁸,Velan S Sendhil¹¹¹⁹,Yen Paul M¹

Affiliation:

1. Cardiovascular & Metabolic Disorders Program, Duke-NUS Graduate Medical School, Singapore

2. Department of Endocrinology and Metabolism, Amsterdam, Netherlands

3. Department of Endocrinology, Tan Tock Seng Hospital, Singapore

4. NTU-Lee Kong Chian School of Medicine, Singapore

5. Singapore Clinical Research Institute, Singapore

6. Department of Endocrinology, Singapore General Hospital, Singapore

7. Department of Medicine, Ng Teng Fong General Hospital, Singapore

8. Department of Endocrinology, Changi General Hospital, Singapore

9. Department of Gastroenterology, Changi General Hospital, Singapore

10. Department of Endocrinology, National University Health System, Singapore

11. Singapore Institute for Clinical Sciences, A*STAR, Singapore

12. Duke University, Nicholas School of the Environment, A220 LSRC, Durham, North Carolina

13. Department of Medicine, University of Melbourne, Austin Health, Heidelberg, Melbourne, Victoria, Australia

14. Department of Gastroenterology, Austin Health, Heidelberg, Victoria, Australia

15. Department of General Medicine, Austin Health, Heidelberg, Victoria, Australia

16. Department of Endocrinology, Khoo Teck Puat Hospital, Singapore

17. Saw Swee Hock School of Public Health, National University Health System, Singapore

18. Diabetes Centre, Admiralty Medical Centre, Singapore

19. Singapore Bioimaging Consortium, Singapore

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/103/7/2698/25123388/jc.2018-00475.pdf

Reference38 articles.

1. Non-alcoholic fatty liver disease: a sign of systemic disease;Reccia;Metabolism,2017

2. Global epidemiology of nonalcoholic fatty liver disease--meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

3. NAFLD in Asia--as common and important as in the West;Farrell;Nat Rev Gastroenterol Hepatol,2013

4. High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels;Portillo-Sanchez;J Clin Endocrinol Metab,2015

5. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients;Targher;Diabetes,2005

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Levothyroxine and Non-alcoholic Fatty Liver Disease: A Mini Review;Mini-Reviews in Medicinal Chemistry;2024-12

2. Impact of peripheral thyroid hormone balance on liver fat: insights from the NutriAct trial;European Journal of Endocrinology;2024-07-25

3. Potential therapeutic strategies for MASH: from preclinical to clinical development;Life Metabolism;2024-07-06

4. Relationship between thyroid hormone levels and metabolic dysfunction associated steatotic liver disease in patients with type 2 diabetes: A clinical study;Medicine;2024-06-28

5. Association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease: an updated meta-analysis;Gut;2024-05-23